AptarGroup (ATR) : Fayerweather Charles reduced its stake in AptarGroup by 0.46% during the most recent quarter end. The investment management company now holds a total of 36,025 shares of AptarGroup which is valued at $2,741,503 after selling 165 shares in AptarGroup , the firm said in a disclosure report filed with the SEC on Aug 8, 2016.AptarGroup makes up approximately 3.72% of Fayerweather Charles’s portfolio.
Other Hedge Funds, Including , Blair William Coil reduced its stake in ATR by selling 3,861 shares or 8.88% in the most recent quarter. The Hedge Fund company now holds 39,629 shares of ATR which is valued at $3,015,767. AptarGroup makes up approx 0.03% of Blair William Coil’s portfolio. Lsv Asset Management added ATR to its portfolio by purchasing 725 company shares during the most recent quarter which is valued at $55,528.Checchi Capital Advisers reduced its stake in ATR by selling 203 shares or 26.89% in the most recent quarter. The Hedge Fund company now holds 552 shares of ATR which is valued at $44,414. AptarGroup makes up approx 0.01% of Checchi Capital Advisers’s portfolio.
AptarGroup closed down -0.08 points or -0.11% at $75.5 with 1,02,963 shares getting traded on Monday. Post opening the session at $75.87, the shares hit an intraday low of $75.48 and an intraday high of $76.08 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, AptarGroup reported $0.91 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.90. The company had revenue of $620.00 million for the quarter, compared to analysts expectations of $620.24 million. The company’s revenue was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.82 EPS.
AptarGroup Inc. is a solution provider of a range of packaging delivery solutions for the beauty personal care home care prescription drug consumer health care injectables food and beverage markets. The Company has manufacturing facilities located throughout the world including North America Europe Asia and South America. It offers various dispensing and sealing solutions. Its primary products are dispensing pumps closures aerosol valves and elastomer primary packaging components. It also manufactures and sells elastomer primary packaging components which include stoppers for infusion antibiotic lyophilization and diagnostic vials. Its elastomer components also include pre-filled syringe components such as plungers needle shields tip caps and cartridges as well as dropper bulbs and disposable syringe plungers. The Company’s segments include Beauty + Home Pharma and Food + Beverage.